• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $CAPS

    Capstone Holding Corp.

    Subscribe to $CAPS
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Capstone Holding Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Capstone Holding Corp. SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Capstone Holding Corp.

    10-K/A - Capstone Holding Corp. (0000887151) (Filer)

    4/17/26 5:15:36 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 10-K/A filed by Capstone Holding Corp.

    10-K/A - Capstone Holding Corp. (0000887151) (Filer)

    4/17/26 4:10:39 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    4/16/26 3:09:28 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Capstone Holding Corp.

    10-K - Capstone Holding Corp. (0000887151) (Filer)

    4/15/26 6:28:32 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form NT 10-K filed by Capstone Holding Corp.

    NT 10-K - Capstone Holding Corp. (0000887151) (Filer)

    3/31/26 4:30:28 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Capstone Holding Corp. filed SEC Form 8-K: Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

    8-K/A - Capstone Holding Corp. (0000887151) (Filer)

    2/17/26 5:25:27 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14C filed by Capstone Holding Corp.

    DEF 14C - Capstone Holding Corp. (0000887151) (Filer)

    2/12/26 4:29:10 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14C filed by Capstone Holding Corp.

    PRE 14C - Capstone Holding Corp. (0000887151) (Filer)

    1/30/26 5:28:57 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    1/28/26 7:30:55 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    1/27/26 7:30:57 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schultz Edward Christopher

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:42:32 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Lipman Matthew E.

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:41:21 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Toporek Michael

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:40:16 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Schultz Edward Christopher

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/22/25 3:55:58 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Lipman Matthew E. claimed ownership of 2,650,436 shares (SEC Form 3)

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/22/25 3:53:49 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Holliman John M Iii claimed ownership of 1,095 shares (SEC Form 3)

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/14/25 7:04:52 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Feldman Fredric J

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/11/25 6:20:35 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings

    Company invites shareholder submissions; FAQ to expand on growth trajectory, margin profile, and path to profitability Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, will publish an investor FAQ during the week of May 4, addressing key questions from its shareholder base. The FAQ will provide additional detail on the Company's recent earnings and 2026 guidance, which includes 54% revenue growth and approximately 4x EBITDA growth. Ahead of publication, Capstone is inviting shareholders to submit questions by emailing [email protected]. Submissions will be reviewed by the Company's leadership team, with a selection of response

    4/21/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

    FY2025 gross margin expands to 23% on $46.9M revenue; FY2026 guidance calls for $72.1M of revenue, ~$18.7M of gross profit (+73%), and a positive EBITDA run-rate starting in Q2 Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. The Company closed FY2025 with ~$46.9 million in revenue and gross margin expanding to 23.0%, reflecting acquisition-driven scale and a higher-margin product mix. For FY2026, Capstone expects revenue to rise 54% to $72.1 million, gross margin to reach 26%, and EBITDA to increase more than fourfold to approximatel

    4/16/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Awarded Eldorado Stone Distribution, Targeting $5 Million in Organic Revenue Growth

    $5 million in organic revenue sold through existing distribution channels with no incremental investment; share-of-wallet capture from existing customers accelerates near-term revenue ramp Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced it has been awarded distribution rights for Eldorado Stone, a premium manufactured stone veneer brand from Westlake Royal Building Products. The Company expects the addition will contribute $5 million in annualized run-rate revenue by Q3 2027, sold entirely through Capstone's existing distribution channels with no incremental infrastructure investment. Capstone is already a top-three national

    4/6/26 7:30:00 AM ET
    $CAPS
    $WLK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Chemicals
    Industrials

    Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth

    The integration of KLAD Envelope Solutions enables direct access to commercial architects and designers, driving high-margin sales mix and proprietary product pull-through; accelerates path to Q2 EBITDA profitability Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced that the integration of KLAD Envelope Solutions, its architectural representative business, is expanding the Company's commercial reach and supporting high-margin sales growth. The integration gives Capstone direct access to commercial customers and is expected to drive proprietary product sales into large-scale projects across multiple geographies. "KLAD's relation

    3/30/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Captures Platform Synergies and Accelerates Path to Positive EBITDA as Revenue Momentum Builds

    Midwest consolidation delivers $0.5 million in annualized savings as part of the Company's $2 million cost rationalization program; over 300,000 square feet of new project demand reinforces growth trajectory Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced that its Midwest distribution consolidation will generate $0.5 million in annualized cost savings and unlock up to $700,000 in working capital. The initiative marks the latest milestone in the Company's previously announced $2 million cost rationalization program. Combined with strong revenue momentum, including more than 300,000 square feet of recently awarded project demand,

    3/24/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Expands Retail Portfolio as Order Volume Accelerates; Contractor Demand Drives Repeat Revenue and EBITDA Growth

    New outdoor living product debuts to strong contractor demand at industry trade shows; recent project wins add immediate cash-generative revenue to the platform Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced the successful launch of a new natural stone firepit product at the iLandscape Show in Illinois. The product will next be showcased at the Northeast Hardscape Expo, following strong contractor demand at its debut. The launch builds on Capstone's recent revenue- and EBITDA-driving project and customer wins by expanding the Company's portfolio of retail-ready SKUs that generate strong repeat order volume. "The reception to

    3/10/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care